Literature DB >> 6197218

Laboratory infection of primates with Ascaris suum to provide a model of allergic bronchoconstriction.

D I Pritchard, R P Eady, S T Harper, D M Jackson, T S Orr, I M Richards, S Trigg, E Wells.   

Abstract

Wild-caught non-human primates are naturally sensitive to Ascaris antigen and provide a useful model for studying atopic asthma. The present study was carried out to determine the effect of experimentally infecting home-bred macaques with the nematode Ascaris suum and hence provide an alternative for the naturally occurring model. Following oral infection with the parasite the animals developed a blood eosinophilia and specific antibodies to purified Ascaris antigen. These antibodies appeared to be of the IgE class as they could be detected by a radiometric assay using a radiolabelled antibody to human IgE. However, on further investigation, using the passive cutaneous anaphylaxis test, two classes of antibody were found, a heat labile (56 degrees C) and a heat stable antibody. Lung lavage cells taken from monkeys infected with Ascaris suum were shown to include cells morphologically characteristic of mast cells and released histamine when challenged in vitro with Ascaris antigen. Hence this model of immediate hypersensitivity provides a simple alternative to the less accessible natural model.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197218      PMCID: PMC1535872     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Ascaris hypersensitivity in the rhesus monkey. I. A model for the study of immediate type thypersensitity in the primate.

Authors:  I Weiszer; R Patterson; J J Pruzansky
Journal:  J Allergy       Date:  1968-01

2.  Short-term anaphylactic IgG antibodies in human sera.

Authors:  W E Parish
Journal:  Lancet       Date:  1970-09-19       Impact factor: 79.321

3.  Isolation of a mast cell degranulating polypeptide from Ascaris suis.

Authors:  B Uvnäs; J K Wold
Journal:  Acta Physiol Scand       Date:  1967 Jul-Aug

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Respiratory responses in subhuman primates with immediate type hypersensitivity.

Authors:  R Patterson; C H Talbot
Journal:  J Lab Clin Med       Date:  1969-06

6.  Toxocara canis infection in baboons. I. Antibody, white-cell, and serum-protein responses following infection.

Authors:  T I Aljeboori; M H Ivey
Journal:  Am J Trop Med Hyg       Date:  1970-03       Impact factor: 2.345

7.  The use of IgE mediated responses as a pharmacologic test system. The effect of disodium cromoglycate in respiratory and cutaneous reactions and on the electrocardiograms of rhesus monkeys.

Authors:  R Patterson; C H Talbot; M Brandfonbrener
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

8.  Antigenic analysis of developmental stages of Ascaris suum. I. Comparison of eggs, larvae and adults.

Authors:  J F Williams; E J Soulsby
Journal:  Exp Parasitol       Date:  1970-02       Impact factor: 2.011

9.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

10.  Toxocara skin sensitivity tests and other observations in animals experimentally infected with Toxocara canis.

Authors:  R A Wiseman; A W Woodruff
Journal:  Trans R Soc Trop Med Hyg       Date:  1967       Impact factor: 2.184

View more
  10 in total

Review 1.  Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

2.  Development of preclinical models for testing antiasthma drugs.

Authors:  T S Orr
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  Alternative modes of action of sodium cromoglycate.

Authors:  I M Richards; M Dixon; D M Jackson; K Vendy
Journal:  Agents Actions       Date:  1986-06

4.  Exposure to Toxocara spp. and Ascaris lumbricoides infections and risk of allergic rhinitis in children.

Authors:  Iraj Mohammadzadeh; Sorena Darvish; Seyed Mohammad Riahi; Solmaz Alizadeh Moghaddam; Mohammad Pournasrollah; Mousa Mohammadnia-Afrozi; Ali Rostami
Journal:  Allergy Asthma Clin Immunol       Date:  2020-07-30       Impact factor: 3.406

5.  Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite.

Authors:  Laura Sanglas; Francesc X Aviles; Robert Huber; F Xavier Gomis-Rüth; Joan L Arolas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 6.  Whipworm and roundworm infections.

Authors:  Kathryn J Else; Jennifer Keiser; Celia V Holland; Richard K Grencis; David B Sattelle; Ricardo T Fujiwara; Lilian L Bueno; Samuel O Asaolu; Oluyomi A Sowemimo; Philip J Cooper
Journal:  Nat Rev Dis Primers       Date:  2020-05-28       Impact factor: 52.329

7.  Ascaris-induced bronchoconstriction in primates experimentally infected with Ascaris suum ova.

Authors:  I M Richards; R P Eady; D M Jackson; T S Orr; D I Pritchard; K Vendy; E Wells
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey.

Authors:  R P Eady; B Greenwood; D M Jackson; T S Orr; E Wells
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

9.  Endotoxin is not essential for the development of cockroach induced allergic airway inflammation.

Authors:  Yoo Seob Shin; Jung-Ho Sohn; Joo-Young Kim; Jae Hyun Lee; Sang-Heon Cho; Soo-Jong Hong; Joo-Shil Lee; Chein-Soo Hong; Jung-Won Park
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

10.  Nonhuman primate models of asthma.

Authors:  Robert L Coffman; Edith M Hessel
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.